Get started
Author

Gili Perry

Observed names: G. Perry, Perry, Gili
ORCID: 0000-0003-0548-4465
Observed ORCID: 0000-0003-0548-4465
OpenAlex ID: A5081908668
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
2020 · Deborah Nejman, Ilana Livyatan, et al. · Science · 2,464
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
2022 · Lian Narunsky-Haziza, Gregory D. Sepich-Poore, et al. · Cell · 538
PDF
Aldolase positively regulates of the canonical Wnt signaling pathway
2014 · Michal Caspi, Gili Perry, et al. · Molecular Cancer · 84
PDF
Proteomic patterns associated with response to breast cancer neoadjuvant treatment
2020 · Anjana Shenoy, Nishanth Belugali Nataraj, et al. · Molecular Systems Biology · 66
mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues
2018 · Noa Bossel Ben-Moshe, Shlomit Gilad, et al. · BMC Genomics · 61
PDF
Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling
2020 · Iris Kamer, Yael Steuerman, et al. · Translational Lung Cancer Research · 27
PDF
Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
2020 · Iris Kamer, Inbal Daniel-Meshulam, et al. · Molecular Cancer Research · 19
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
2016 · Maya Dadiani, Noa Bossel Ben-Moshe, et al. · Clinical Cancer Research · 12
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation
2025 · Maya Dadiani, Gilgi Friedlander, et al. · Molecular Oncology · 2
PDF
Divergence of mutational signatures in association with breast cancer subtype
2022 · Gili Perry, Maya Dadiani, et al. · Molecular Carcinogenesis · 2
PDF
Abstract 3054: Pan-cancer characterization of the tumor mycobiome and its clinical effects
2022 · Lian Narunsky Haziza, Gregory D. Sepich-Poore, et al. · Cancer Research · 1
InSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment
2026 · Tal Goldberg, Michal Danino-Levi, et al. · Nucleic Acids Research
Author response for "Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation"
2024 · Maya Dadiani, Gilgi Friedlander, et al. · Publons reviews and discussion
Supplementary figures from Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
2023 · Iris Kamer, Inbal Daniel-Meshulam, et al.
Supplementary figures from Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
2023 · Iris Kamer, Inbal Daniel-Meshulam, et al.
Data from Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
2023 · Iris Kamer, Inbal Daniel-Meshulam, et al.
Data from Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
2023 · Iris Kamer, Inbal Daniel-Meshulam, et al.
Supp Data from Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
2023 · Maya Dadiani, Noa Bossel Ben-Moshe, et al.
PDF
Supp Data from Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
2023 · Maya Dadiani, Noa Bossel Ben-Moshe, et al.
Data from Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
2023 · Maya Dadiani, Noa Bossel Ben-Moshe, et al.
Data from Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
2023 · Maya Dadiani, Noa Bossel Ben-Moshe, et al.
Abstract P6-03-01: Mapping a personalized chemo-resistome in breast cancer patients by longitudinal transcriptomics
2020 · Maya Dadiani, Gilgi Friedlander, et al. · Cancer Research
PO-312 Longitudinal transcriptomics reveals heterogeneous dynamics through the course of disease and therapy in breast cancer
2018 · M. Dadiani, G. Friedlander, et al. · ESMO Open
Abstract 1153: Stromal FoxM1 and p53 in lung cancer as mediators of tumor progression, metastatic spread and chemo-resistance
2014 · Iris Kamer, Inbal Daniel, et al. · Cancer Research
Works count: 31
Citation count: 3,276
H-index: 8
I10-index: 8
Year
Topic
Type